
Full profile: /officials/M000194
Source: Congress.gov · FEC
Members who have signed on to support this bill since introduction. Source: Congress.gov.
The most recent step in the bill's legislative path. Committee Activity below shows referrals and reports; the full action-by-action history including floor proceedings lives at Congress.gov →
Currently in
Previously
The proposal would establish new protections and requirements for how pharmaceutical companies handle and report information about their drugs' safety and effectiveness. It aims to give patients and healthcare providers better access to data about medication risks and benefits so they can make more informed decisions about treatment options. The measure would affect drug manufacturers, healthcare professionals, and patients who rely on prescription and over-the-counter medications.
AI-assisted summary generated from the official bill metadata (title, subjects, actions) sourced from Congress.gov. Cached and reviewed. Always verify against the official text linked below.
Bills by the same sponsor or covering overlapping subjects.